<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Effects of variation in CYP2D6 metabolism with clinical response to two therapeutic agents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Effects of variation in CYP2D6 metabolism with clinical response to two therapeutic agents</h1>
<div class="graphic"><div class="figure"><div class="ttl">Effects of variation in CYP2D6 metabolism with clinical response to two therapeutic agents</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Based upon genetic make-up and the resultant ability to metabolize therapeutic agents, individuals can be classified as extensive (normal) metabolizers (EM), poor metabolizers (PM), or ultrarapid metabolizers (UM). Since codeine is metabolized into an active agent (morphine), poor metabolizers may require increased dosing for a given therapeutic effect, while ultrarapid metabolizers may build up excessive levels of morphine, leading to adverse sequelae. Conversely, nortriptyline is the active therapeutic agent and is metabolized to an inactive form. In this case, poor metabolism leads to adequate therapy but an increased incidence of side effects, while extensive metabolizers may require increased dosing for therapeutic effect.</div><div class="graphic_footnotes">C: codeine; M: morphine; N: nortriptyline; I: inactive nortriptyline; EM: extensive metabolizers; PM: poor metabolizers; UM: ultrarapid metabolizers.</div><div class="graphic_reference">Reproduced with permission from PharmGKB. Copyright © 2009.</div><div id="graphicVersion">Graphic 55020 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
